{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17361185",
  "DateCompleted": {
    "Year": "2007",
    "Month": "04",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1476-4687",
      "JournalIssue": {
        "Volume": "446",
        "Issue": "7133",
        "PubDate": {
          "Year": "2007",
          "Month": "Mar",
          "Day": "15"
        }
      },
      "Title": "Nature",
      "ISOAbbreviation": "Nature"
    },
    "ArticleTitle": "14-3-3sigma controls mitotic translation to facilitate cytokinesis.",
    "Pagination": {
      "StartPage": "329",
      "EndPage": "332",
      "MedlinePgn": "329-32"
    },
    "Abstract": {
      "AbstractText": [
        "14-3-3 proteins are crucial in a wide variety of cellular responses including cell cycle progression, DNA damage checkpoints and apoptosis. One particular 14-3-3 isoform, sigma, is a p53-responsive gene, the function of which is frequently lost in human tumours, including breast and prostate cancers as a result of either hypermethylation of the 14-3-3sigma promoter or induction of an oestrogen-responsive ubiquitin ligase that specifically targets 14-3-3sigma for proteasomal degradation. Loss of 14-3-3sigma protein occurs not only within the tumours themselves but also in the surrounding pre-dysplastic tissue (so-called field cancerization), indicating that 14-3-3sigma might have an important tumour suppressor function that becomes lost early in the process of tumour evolution. The molecular basis for the tumour suppressor function of 14-3-3sigma is unknown. Here we report a previously unknown function for 14-3-3sigma as a regulator of mitotic translation through its direct mitosis-specific binding to a variety of translation/initiation factors, including eukaryotic initiation factor 4B in a stoichiometric manner. Cells lacking 14-3-3sigma, in marked contrast to normal cells, cannot suppress cap-dependent translation and do not stimulate cap-independent translation during and immediately after mitosis. This defective switch in the mechanism of translation results in reduced mitotic-specific expression of the endogenous internal ribosomal entry site (IRES)-dependent form of the cyclin-dependent kinase Cdk11 (p58 PITSLRE), leading to impaired cytokinesis, loss of Polo-like kinase-1 at the midbody, and the accumulation of binucleate cells. The aberrant mitotic phenotype of 14-3-3sigma-depleted cells can be rescued by forced expression of p58 PITSLRE or by extinguishing cap-dependent translation and increasing cap-independent translation during mitosis by using rapamycin. Our findings show how aberrant mitotic translation in the absence of 14-3-3sigma impairs mitotic exit to generate binucleate cells and provides a potential explanation of how 14-3-3sigma-deficient cells may progress on the path to aneuploidy and tumorigenesis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA."
          }
        ],
        "LastName": "Wilker",
        "ForeName": "Erik W",
        "Initials": "EW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "van Vugt",
        "ForeName": "Marcel A T M",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Artim",
        "ForeName": "Steven A",
        "Initials": "SA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Huang",
        "ForeName": "Paul H",
        "Initials": "PH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Petersen",
        "ForeName": "Christian P",
        "Initials": "CP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Reinhardt",
        "ForeName": "H Christian",
        "Initials": "HC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Feng",
        "ForeName": "Yun",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sharp",
        "ForeName": "Phillip A",
        "Initials": "PA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sonenberg",
        "ForeName": "Nahum",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "White",
        "ForeName": "Forest M",
        "Initials": "FM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yaffe",
        "ForeName": "Michael B",
        "Initials": "MB"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nature",
    "NlmUniqueID": "0410462",
    "ISSNLinking": "0028-0836"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "14-3-3 Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Eukaryotic Initiation Factors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Neoplasm Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA Caps"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "eIF-4B"
    },
    {
      "RegistryNumber": "EC 3.1.-",
      "NameOfSubstance": "Exonucleases"
    },
    {
      "RegistryNumber": "EC 3.1.-",
      "NameOfSubstance": "Exoribonucleases"
    },
    {
      "RegistryNumber": "EC 3.1.-",
      "NameOfSubstance": "SFN protein, human"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Nature. 2007 Mar 15;446(7133):274-5",
      "PMID": "17361171"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "14-3-3 Proteins"
    },
    {
      "QualifierName": [
        "deficiency",
        "metabolism"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cytokinesis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Eukaryotic Initiation Factors"
    },
    {
      "QualifierName": [
        "deficiency",
        "metabolism"
      ],
      "DescriptorName": "Exonucleases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exoribonucleases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mitosis"
    },
    {
      "QualifierName": [
        "deficiency",
        "metabolism"
      ],
      "DescriptorName": "Neoplasm Proteins"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Protein Biosynthesis"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "RNA Caps"
    }
  ]
}